Citation:Hubble D, Kong G, Michael M, Johnson V, Ramdave S, Hicks RJ 2010

From Cancer Guidelines Wiki

Citation


Hubble D, Kong G, Michael M, Johnson V, Ramdave S, Hicks RJ. 177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide. Eur J Nucl Med Mol Imaging 2010 Oct;37(10):1869-75 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/20445977.



Critical appraisals


Compare quality appraisals for each clinical question

Cited by

  1. NETs guidelines/Radionuclide Therapy